Franklin Templeton Biotechnology Accumulation Units

Sell : 56.55p | Buy : 56.55p | down 3.18p
Last valuation as at 21-11-2008

At a glance

Initial charge 5.00%
Initial saving 5.00%
Annual charge 1.50%
Annual saving 0.250% ²
Total Expense Ratio 1.73%
Launch date 10-07-2000
Launch price £1.00
Sector Specialist
Fund size £6 million
Number of holdings 55
Fund type OEIC
Type of units Accumulation

HL Research - Our view on this Fund

Hargreaves Lansdown research covers the funds we currently highlight and the most popular funds chosen by our clients over the years. This fund does not fall into either of these categories at present.

Full research

About the Fund Manager

Photo of Evan McCulloch

Evan McCulloch
Located in: California, United States


Evan McCulloch is a vice president and portfolio manager for Franklin Advisers, Inc. Mr. McCulloch also specialises in research analysis of the health care industry; including pharmaceuticals, health care information systems/internet and health care providers.

Mr. McCulloch joined Franklin Templeton Investments in 1992 as a management trainee. He received a bachelor's degree in economics from the University of California at Berkeley. He is a Chartered Financial Analyst (CFA) and a member of the Association for Investment Management and Research (AIMR) and the Security Analysts of San Francisco (SAs/f).

Previous 1 of 2 Next

Income details

Running yield N/a
Income paid N/a
Type of payment No income

All yields are variable and not guaranteed. There is currently no yield information available for this fund.

Distribution dates

Ex-dividend date 31 March 2008
Payment date ³ 31 May 2008

Top 10 holdings

Gilead Sciences 10.87%
Genzyme Corp. 10.51%
Genentech 10.09%
Celgene Corp. 9.39%
Amgen 5.53%
Biogen Idec 4.36%
Teva Pharmaceutical Industries Ltd. ADS 4.29%
Sequenom 3.86%
PDL BioPharma 2.77%
OSI Pharmaceuticals 2.44%

Top 10 sectors

Pharmaceuticals & Biotechnology 86.93%
Cash and Equiv. 12.27%
Health Care Equipment & Services 0.67%
Financial Services 0.12%

Top 10 countries

United States 82.01%
Cash and Equiv. 12.27%
Israel 4.29%
Canada 0.93%
China 0.27%
Italy 0.13%
Australia 0.10%

² Annual saving is not available in the SIPP.

³ If you elect to receive the income from a Vantage ISA, Fund or Share Account, we will collect any dividends for you and then pay them directly into your bank account within the first 10 working days of the following month.

Last valuation as at 21-11-2008. Data accurate as at 31/03/2005.

Data provided by
FundsLibrary